Learn About Ocrevus Infusion Schedule and Treatment Process

Ocrevus, also known as ocrelizumab, is a prescription medicine used to treat certain forms of multiple sclerosis, including relapsing forms and primary progressive multiple sclerosis in appropriate patients. It is given through an intravenous infusion under medical supervision. The schedule is designed to provide ongoing treatment while allowing healthcare professionals to monitor the patient's response and safety.

Ocrevus Infusion Schedule

The initial Ocrevus treatment is generally divided into two separate infusions. These first doses are administered two weeks apart. After the initial treatment, subsequent maintenance infusions are typically given once every six months. The exact timing can depend on the patient's treatment plan and healthcare provider's recommendations.

• Initial dose is divided into two 300 mg infusions.
• The first and second initial infusions are usually separated by two weeks.
• Later doses are generally 600 mg infusions given approximately every six months.
• Healthcare professionals determine the appropriate timing for each treatment.
• The schedule may be adjusted when clinically necessary.

Before an infusion, healthcare professionals may review the patient's current health, medications, previous reactions, and infection history. Premedication may also be provided before Ocrevus to reduce the likelihood or severity of infusion-related reactions.

Ocrevus Treatment Process

Ocrevus is administered through an intravenous line at a healthcare facility. During the infusion, medical staff monitor the patient for possible reactions. The length of an appointment can vary depending on the dose, infusion rate, monitoring requirements, and individual circumstances.

• The healthcare team checks the patient before treatment.
• Recommended premedications may be administered before the infusion.
• Ocrevus is delivered intravenously at a controlled rate.
• Patients are monitored during and after the infusion.
• Healthcare professionals provide instructions about symptoms that may require medical attention.
• Follow-up appointments help assess treatment progress and ongoing safety.

Infusion-related reactions can include symptoms such as itching, rash, throat irritation, flushing, headache, fever, or changes in blood pressure. Patients should promptly tell healthcare staff about any unusual symptoms during treatment. Serious reactions are less common but require immediate medical attention.

Ocrevus treatment may also affect certain immune cells, so healthcare professionals consider infection risks and other health factors when planning treatment. Patients should discuss vaccinations, infections, other medications, and any significant health changes with their healthcare provider before receiving an infusion.

Understanding the Ocrevus infusion schedule can help patients prepare for appointments and follow their prescribed treatment plan. Because treatment decisions depend on individual medical circumstances, the healthcare team determines the appropriate dosing, timing, monitoring, and follow-up care. This information is for educational purposes only and does not replace advice from a qualified healthcare professional.